help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karl, M.
Right arrow Articles by Elliot, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karl, M.
Right arrow Articles by Elliot, S. J.
(American Journal of Pathology. 2006;169:351-361.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051255

Differential Effects of Continuous and Intermittent 17ß-Estradiol Replacement and Tamoxifen Therapy on the Prevention of Glomerulosclerosis

Modulation of the Mesangial Cell Phenotype in Vivo

Michael Karl, Mariana Berho, Judith Pignac-Kobinger, Gary E. Striker and Sharon J. Elliot

From the Vascular Biology Institute, Leonard M. Miller School of Medicine at the University of Miami, Miami, Florida

Female ROP Os/+ mice are partially protected by endogenous estrogens against progressive glomerulosclerosis (GS) during their reproductive period; however, ovariectomy accelerates GS progression. We examined the effects of continuous and intermittent 17ß-estradiol (E2) replacement and tamoxifen therapy on the development of GS in ovariectomized (Ovx) ROP Os/+ mice. Continuous E2 replacement (CE2) throughout 9 months prevented microalbuminuria and excess extracellular matrix accumulation in Ovx ROP Os/+, not only compared to placebo-treated Ovx mice but also in comparison to intact female ROP Os/+. Tamoxifen had a similar effect, but of lesser magnitude. Intermittent 3-month on-off-on E2 did not reduce the kidney changes. Mesangial cells (MCs) from CE2 mice maintained their estrogen responsiveness. E2 in vitro prevented transforming growth factor-ß1 stimulation of a Smad-responsive reporter construct and increased MMP-2 expression and activity in MCs isolated from CE2 mice. MCs from mice on either placebo or intermittent E2 treatment did not respond to added E2, consistent with a stable alteration of their estrogen responsiveness. Tamoxifen protection against GS was less pronounced in ROP Os/+ mice. Thus, prolonged estrogen deficiency promotes GS and renders MCs insensitive to subsequent estrogen treatment. This underscores the importance of continuous estrogen exposure for maintaining glomerular function and structure in females susceptible to progressive GS.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Dixon and C. Maric
17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1678 - F1690.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. J. Elliot, M. Karl, M. Berho, X. Xia, S. Pereria-Simon, D. Espinosa-Heidmann, and G. E. Striker
Smoking Induces Glomerulosclerosis in Aging Estrogen-Deficient Mice through Cross-Talk between TGF-beta1 and IGF-I Signaling Pathways
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3315 - 3324.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.